Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Long-term Follow-up Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)

NCT04049084 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04049084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Long-term Follow-up Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 26, 2019
Completion date
August 31, 2040
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenosine deaminase deficiency, severe combined immunodeficiency (scid)